Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Ocata Therapeutics Inc

ACTC:US

Ticker Change

Company Profile for Ocata Therapeutics Inc (ACTC)

Ocata Therapeutics Inc is a biotechnology company that provides medical research services. The Company applies human embryonic stem cell technology in regenerative medicine for retinal and cardiovascular diseases.

Contact Information

Ocata Therapeutics Inc

33 Locke Drive
Marlborough, MA 01752
United States
Phone: 1-508-756-1212
Fax: 1-508-229-2333

Key Executives for Ocata Therapeutics Inc (ACTC)

Paul K WottonPresident/CEOEdward H Myles "Ted"CFO/COO
Robert P LanzaChief Scientific OfficerEddy AngladeExec VP:Clinical Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil